Christian S Kendall, a director at $NOV, bought 50,000 shares of the company on 11-21-2025 for an estimated $725,000. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 139.1%. Following this trade, they now own 85,949 shares of this class of $NOV stock.
$NOV Insider Trading Activity
$NOV insiders have traded $NOV stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NOV stock by insiders over the last 6 months:
- CHRISTIAN S KENDALL has made 2 purchases buying 70,000 shares for an estimated $1,012,200 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NOV Hedge Fund Activity
We have seen 220 institutional investors add shares of $NOV stock to their portfolio, and 260 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OLDFIELD PARTNERS LLP added 4,768,371 shares (+inf%) to their portfolio in Q3 2025, for an estimated $63,180,915
- AMERICAN CENTURY COMPANIES INC added 2,304,975 shares (+43.6%) to their portfolio in Q3 2025, for an estimated $30,540,918
- ROYAL BANK OF CANADA added 1,589,902 shares (+170.1%) to their portfolio in Q3 2025, for an estimated $21,066,201
- ALYESKA INVESTMENT GROUP, L.P. removed 1,308,452 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $16,264,058
- POLARIS CAPITAL MANAGEMENT, LLC removed 1,303,660 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $17,273,495
- LOOMIS SAYLES & CO L P removed 1,257,933 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $15,636,107
- BLACKROCK, INC. removed 1,110,867 shares (-2.8%) from their portfolio in Q3 2025, for an estimated $14,718,987
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NOV Congressional Stock Trading
Members of Congress have traded $NOV stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $NOV stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/24 and 1 sale worth up to $15,000 on 07/16.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NOV Analyst Ratings
Wall Street analysts have issued reports on $NOV in the last several months. We have seen 3 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Underweight" rating on 10/30/2025
- Stifel issued a "Buy" rating on 10/29/2025
- RBC Capital issued a "Outperform" rating on 10/29/2025
- Susquehanna issued a "Positive" rating on 07/30/2025
- Wells Fargo issued a "Underweight" rating on 06/05/2025
To track analyst ratings and price targets for $NOV, check out Quiver Quantitative's $NOV forecast page.
$NOV Price Targets
Multiple analysts have issued price targets for $NOV recently. We have seen 10 analysts offer price targets for $NOV in the last 6 months, with a median target of $14.5.
Here are some recent targets:
- Scott Gruber from Citigroup set a target price of $16.0 on 11/12/2025
- David Anderson from Barclays set a target price of $13.0 on 11/11/2025
- Neil Mehta from Goldman Sachs set a target price of $14.0 on 11/05/2025
- Stephen Gengaro from Stifel set a target price of $19.0 on 10/29/2025
- Keith Mackey from RBC Capital set a target price of $19.0 on 10/29/2025
- Luke Lemoine from Piper Sandler set a target price of $14.0 on 08/14/2025
- Arun Jayaram from JP Morgan set a target price of $15.0 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
